Nabriva Therapeutics plc Employment Agreements
11 Contracts & Agreements
- Employment Agreement dated August 23, 2021 by and between Nabriva Therapeutics US, Inc. and Christine Guico-Pabia (Filed With SEC on November 9, 2021)
- Employment Agreement dated August 24, 2021 by and between Nabriva Therapeutics US, Inc. and J. Christopher Naftzger (Filed With SEC on November 9, 2021)
- Employment Agreement, by and between Nabriva Therapeutics US, Inc. and Daniel Dolan, dated as of March 10, 2021 (Filed With SEC on March 11, 2021)
- Third Amended and Restated Employment Agreement by and between Nabriva Therapeutics US, Inc. and Steven Gelone, dated as of March 10, 2021 (Filed With SEC on March 11, 2021)
- Amended and Restated Employment Agreement, by and between Nabriva Therapeutics US, Inc. and Theodore Schroeder, dated as of March 10, 2021 (Filed With SEC on March 11, 2021)
- Amended and Restated Employment Agreement, by and between Nabriva Therapeutics US, Inc. and Robert Crotty, dated as of March 10, 2021 (Filed With SEC on March 11, 2021)
- Employment Agreement, by and between Nabriva Therapeutics US, Inc. and Jennifer Schranz, dated as of March 21, 2018 (Filed With SEC on March 12, 2019)
- Second Amended and Restated Employment Agreement by and between Nabriva Therapeutics US, Inc. and Steven Gelone, dated as of July 24, 2018 (Filed With SEC on November 6, 2018)
- Employment Agreement, by and between Nabriva Therapeutics US, Inc. and Theodore Schroeder, dated as of July 23, 2018 (Filed With SEC on July 25, 2018)
- EMPLOYMENT AGREEMENT (Filed With SEC on August 7, 2017)
- EMPLOYMENT AGREEMENT (Filed With SEC on August 7, 2017)
